Clinical Trials in Ballwin, United States
Locations / Ballwin, United States
Delta Trials records 52 clinical trials conducted in Ballwin, United States, making it a notable site of clinical research activity. These trials across 403 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Ballwin has changed over time.
52
Total Trials
403
Conditions
0
Terminated since 2020
Browse by condition (403 total)
- Stage iiib lung cancer ajcc v8 4 trialsAll Stage iiib lung cancer ajcc v8 trials
- Small lymphocytic lymphoma 3 trialsAll Small lymphocytic lymphoma trials
- Malignant solid neoplasm 3 trialsAll Malignant solid neoplasm trials
- All Recurrent ovarian endometrioid adenocarcinoma trials
- Stage iv lung cancer ajcc v8 3 trialsAll Stage iv lung cancer ajcc v8 trials
- Chronic lymphocytic leukemia 3 trialsAll Chronic lymphocytic leukemia trials
- All Recurrent ovarian clear cell adenocarcinoma trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- Stage iiia lung cancer ajcc v8 3 trialsAll Stage iiia lung cancer ajcc v8 trials
- Lung non-small cell carcinoma 3 trialsAll Lung non-small cell carcinoma trials
- All Anatomic stage iii breast cancer ajcc v8 trials
- Clear cell renal cell carcinoma 2 trialsAll Clear cell renal cell carcinoma trials
- Triple-negative breast carcinoma 2 trialsAll Triple-negative breast carcinoma trials
- Recurrent ovarian carcinoma 2 trialsAll Recurrent ovarian carcinoma trials
- Stage ivb prostate cancer ajcc v8 2 trialsAll Stage ivb prostate cancer ajcc v8 trials
- Stage iii breast cancer ajcc v7 2 trialsAll Stage iii breast cancer ajcc v7 trials
- All Recurrent lung non-squamous non-small cell carcinoma trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- Ovarian seromucinous carcinoma 2 trialsAll Ovarian seromucinous carcinoma trials
- Cervical adenocarcinoma 2 trialsAll Cervical adenocarcinoma trials